Prognostic Value of Red Blood Cell Distribution Width (RDW) in the Recurrence of Hepatocellular Carcinoma Following Curative Resection
Mohammad Golriz,Ali Ramouz,Sadeq Ali-Hasan-Al-Saegh,Saeed Shafiei,Ehsan Aminizadeh,Ahmed Hammad,Markus Mieth,Christian Rupp,Christoph Springfeld,Katrin Hoffmann,Markus Büchler,Arianeb Mehrabi
DOI: https://doi.org/10.2147/JHC.S380243
2022-11-03
Journal of Hepatocellular Carcinoma
Abstract:Mohammad Golriz, 1, 2 Ali Ramouz, 1 Sadeq Ali-Hasan-Al-Saegh, 1 Saeed Shafiei, 1 Ehsan Aminizadeh, 1 Ahmed Hammad, 1 Markus Mieth, 1 Christian Rupp, 2, 3 Christoph Springfeld, 2, 4 Katrin Hoffmann, 1, 2 Markus Büchler, 1 Arianeb Mehrabi 1, 2 1 Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany; 2 Liver Cancer Center Heidelberg (LCCH), Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany; 3 Department of Internal Medicine IV, Gastroenterology & Hepatology, Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany; 4 National Center for Tumor Diseases, Department of Medical Oncology, Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany Correspondence: Arianeb Mehrabi, Head of the Division of Liver Surgery and Visceral Transplantation, Department of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany, Tel +49– 6221– 5636223, Fax +49– 6221– 567470, Email Purpose: Although surgery is associated with an acceptable cure rate, tumor recurrence is still a challenging issue in hepatocellular carcinoma (HCC) patients. Red blood cell distribution width (RDW) is considered an inflammatory marker for predicting overall mortality in a wide spectrum of malignancies. In the current study, the prognostic role of pre- and postoperative RDW in HCC recurrence after liver resection (LRx) is investigated. Patients and Methods: In 395 patients, RDW levels were evaluated preoperatively as well as six and twelve months after curative LRx. The RDW cutoff values were determined using receiver operating characteristic curves (ROCs) according to the recurrence-free survival (RFS). Survival analyses were performed using the Kaplan–Meier, and differences were compared using the Log rank test. Results: The RFS was significantly higher among patients with low RDW at the 6th month and 12th month, postoperatively (P < 0.001 and P = 0.028). RDW levels of higher than 16.15% at the 6th (HR: 2.047, P < 0.001) and higher than 15.85% at 12th (HR: 3.105, P < 0.002) months after liver resection were independent predictors of RFS. Conclusion: Postoperative RDW values seem to be predictive of tumor recurrence in HCC patients. RDW levels at the 6th and 12th months postoperatively were independent predictors of recurrence after LRx. Keywords: hepatectomy, hepatocellular carcinoma, liver resection, red blood cell distribution width Hepatocellular carcinoma (HCC) is one of the most common types of solid organ cancers worldwide with poor prognosis and is the second leading cause of cancer-related death. 1 In recent decades, the incidence and prevalence of HCC has been increasing considerably, especially in high-risk patients. 1,2 Moreover, the advances in clinical therapeutics and management have led to prolonged survival of the patients, whereas no significant contribution has been made over the past four decades to increase the survival rates, in solid malignancies such as HCC. Although surgical resection is associated with an acceptable cure rate, tumor recurrence is still a challenging issue, and the underlying etiology has yet to be fully elucidated. 3 Therefore, different biomarkers have been suggested to predict recurrence after resection, among which red blood cell distribution width (RDW) is one of the most easily available markers. 4,5 RDW is a hematological parameter for volume variability of erythrocytes in peripheral blood. Some studies have shown a strong association between RDW and age of the patients, however, its correlation with gender remains still unclear. 6 Besides, other investigations have criticized the overestimated effect of the aging over RDW levels, due to neglection of habitual marrow stimulations in healthy individuals. Nonetheless, several studies have considered the RDW as an inflammation-associated marker for predicting overall mortality in a wide spectrum of malignancies. 7–10 The possible mechanism may be inflammation-associated impairment in erythrocyte maturation, oxidative stress, deranged nutrition, and cancer-driven cytokine release. 11–14 Specifically, for HCC, preoperative RDW has been shown to be able to predict the post resection recurrence of the tumor and mortality of patients. 4,15 However, these studies focused only on preoperative RDW levels. To the best of our knowledge, there is no study evaluating the significance of pre- -Abstract Truncated-
oncology